Quest Diagnostics Incorporated
NYSE:DGX
154.33 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 9,252 | 9,883 | 10,788 | 9,437 | 7,726 | 7,531 | 7,709 | 7,515 | 7,493 | 7,435 | 7,146 | 7,382.6 | 7,510.5 | 7,368.9 | 7,455.2 | 7,249.4 | 6,704.907 | 6,268.659 | 5,503.711 | 5,126.601 | 4,737.958 | 4,108.051 | 3,627.771 | 3,421.162 | 2,205.2 | 1,458.6 | 1,528.7 | 1,616.296 |
| Cost of Revenue
| 6,291 | 6,450 | 6,579 | 5,804 | 5,037 | 4,926 | 4,719 | 4,616 | 4,657 | 4,637 | 4,326 | 4,364.7 | 4,395.3 | 4,317.2 | 4,321.5 | 4,256.1 | 3,969.848 | 3,696.006 | 3,257.335 | 2,990.712 | 2,768.623 | 2,432.388 | 2,151.594 | 1,967.606 | 1,319 | 813.9 | 875.5 | 1,010.875 |
| Gross Profit
| 2,961 | 3,433 | 4,209 | 3,633 | 2,689 | 2,605 | 2,990 | 2,899 | 2,836 | 2,798 | 2,820 | 3,017.9 | 3,115.2 | 3,051.7 | 3,133.7 | 2,993.3 | 2,735.059 | 2,572.653 | 2,246.376 | 2,135.889 | 1,969.335 | 1,675.663 | 1,476.177 | 1,453.556 | 886.2 | 644.7 | 653.2 | 605.421 |
| Gross Profit Ratio
| 0.32 | 0.347 | 0.39 | 0.385 | 0.348 | 0.346 | 0.388 | 0.386 | 0.378 | 0.376 | 0.395 | 0.409 | 0.415 | 0.414 | 0.42 | 0.413 | 0.408 | 0.41 | 0.408 | 0.417 | 0.416 | 0.408 | 0.407 | 0.425 | 0.402 | 0.442 | 0.427 | 0.375 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 1,424 | 1,750 | 1,681 | 1,679 | 1,728 | 1,704 | 1,745.2 | 1,814.315 | 1,707.673 | 1,747.618 | 1,736.934 | 1,612.858 | 1,433.733 | 1,257.775 | 1,227.746 | 1,165.7 | 1,074.841 | 1,018.68 | 1,001.443 | 643.4 | 481.6 | 502.1 | 495.323 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.015 | 0.027 | -0.018 | -0.034 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 1,610 | 1,874 | 1,727 | 1,550 | 1,457 | 1,424 | 1,750 | 1,681 | 1,679 | 1,728 | 1,704 | 1,745.2 | 1,814.3 | 1,707.7 | 1,747.6 | 1,736.9 | 1,612.858 | 1,433.733 | 1,257.775 | 1,227.746 | 1,165.7 | 1,074.841 | 1,018.68 | 1,001.443 | 643.4 | 481.6 | 502.1 | 495.323 |
| Other Expenses
| 20 | 131 | 101 | 112 | 1 | -8 | 16 | -48 | -143 | 4 | 8 | 6.7 | 305.794 | 48.47 | 27.039 | 33.981 | 30.865 | 10.913 | 20.49 | 6.703 | 8.201 | 8.373 | 46.107 | 134.296 | 90.8 | 68.8 | 76.4 | 711.382 |
| Operating Expenses
| 1,610 | 2,005 | 1,828 | 1,662 | 1,458 | 1,500 | 1,825 | 1,740 | 1,771 | 1,815 | 1,819 | 1,817.1 | 2,120.2 | 1,756.2 | 1,774.6 | 1,770.9 | 1,643.723 | 1,444.646 | 1,278.265 | 1,234.449 | 1,173.901 | 1,083.214 | 1,064.787 | 1,135.739 | 734.2 | 550.4 | 578.5 | 1,206.705 |
| Operating Income
| 1,351 | 1,428 | 2,381 | 1,971 | 1,231 | 1,101 | 1,165 | 1,277 | 1,399 | 983 | 1,475 | 1,200.8 | 995 | 1,295.5 | 1,359.1 | 1,222.4 | 1,091.336 | 1,128.007 | 968.111 | 901.44 | 795.434 | 592.449 | 411.39 | 317.817 | 152 | 94.3 | 74.7 | -601.284 |
| Operating Income Ratio
| 0.146 | 0.144 | 0.221 | 0.209 | 0.159 | 0.146 | 0.151 | 0.17 | 0.187 | 0.132 | 0.206 | 0.163 | 0.132 | 0.176 | 0.182 | 0.169 | 0.163 | 0.18 | 0.176 | 0.176 | 0.168 | 0.144 | 0.113 | 0.093 | 0.069 | 0.065 | 0.049 | -0.372 |
| Total Other Income Expenses Net
| -221 | -193 | 218 | -87 | -155 | -12 | 16 | 70 | 191 | 30 | 506 | 32.3 | 31.9 | 34.9 | 12.9 | -23.7 | 22.929 | 20.521 | 3.549 | 10.988 | 19.783 | 18.475 | 1.69 | -3.744 | -76 | -7 | -52.8 | -74.918 |
| Income Before Tax
| 1,130 | 1,235 | 2,599 | 1,884 | 1,076 | 926 | 1,030 | 1,086 | 1,103 | 849 | 1,348 | 1,068.4 | 856.3 | 1,184.3 | 1,227.9 | 1,019 | 912.402 | 1,033.273 | 910.454 | 835.126 | 737.798 | 542.377 | 332.604 | 200.981 | 14.4 | 53.9 | -19.1 | -676.202 |
| Income Before Tax Ratio
| 0.122 | 0.125 | 0.241 | 0.2 | 0.139 | 0.123 | 0.134 | 0.145 | 0.147 | 0.114 | 0.189 | 0.145 | 0.114 | 0.161 | 0.165 | 0.141 | 0.136 | 0.165 | 0.165 | 0.163 | 0.156 | 0.132 | 0.092 | 0.059 | 0.007 | 0.037 | -0.012 | -0.418 |
| Income Tax Expense
| 248 | 264 | 597 | 460 | 247 | 182 | 241 | 429 | 373 | 262 | 500 | 401.9 | 349 | 425.5 | 460.4 | 386.8 | 358.574 | 407.581 | 364.177 | 335.931 | 301.081 | 220.223 | 148.692 | 96.033 | 15.7 | 27 | 3.2 | -50.242 |
| Net Income
| 854 | 946 | 1,995 | 1,431 | 858 | 736 | 772 | 645 | 709 | 556 | 849 | 555.7 | 470.6 | 720.9 | 729.1 | 581.5 | 339.939 | 586.421 | 546.277 | 499.195 | 436.717 | 322.154 | 162.303 | 102.052 | -3.4 | 26.9 | -22.3 | -625.96 |
| Net Income Ratio
| 0.092 | 0.096 | 0.185 | 0.152 | 0.111 | 0.098 | 0.1 | 0.086 | 0.095 | 0.075 | 0.119 | 0.075 | 0.063 | 0.098 | 0.098 | 0.08 | 0.051 | 0.094 | 0.099 | 0.097 | 0.092 | 0.078 | 0.045 | 0.03 | -0.002 | 0.018 | -0.015 | -0.387 |
| EPS
| 7.59 | 8.12 | 15.9 | 10.68 | 6.38 | 5.41 | 5.63 | 4.58 | 4.92 | 3.83 | 5.58 | 3.49 | 2.95 | 4.08 | 3.91 | 2.99 | 1.76 | 2.98 | 2.71 | 2.45 | 2.11 | 1.67 | 0.87 | 0.57 | -0.025 | 0.23 | -0.19 | -5.33 |
| EPS Diluted
| 7.52 | 7.98 | 15.53 | 10.52 | 6.29 | 5.29 | 5.5 | 4.51 | 4.87 | 3.81 | 5.54 | 3.46 | 2.92 | 4.05 | 3.87 | 2.97 | 1.74 | 2.94 | 2.66 | 2.35 | 2.02 | 1.62 | 0.83 | 0.54 | -0.025 | 0.22 | -0.19 | -5.33 |
| EBITDA
| 1,790 | 1,810 | 3,158 | 2,408 | 1,580 | 1,406 | 1,451 | 1,360 | 1,560 | 1,327 | 1,316 | 1,519.7 | 1,305.1 | 1,579.1 | 1,649.1 | 1,540.4 | 1,333.255 | 1,333.353 | 1,166.871 | 1,080.227 | 946.993 | 705.365 | 557.427 | 455.857 | 318.8 | 170.1 | 203.9 | -502.186 |
| EBITDA Ratio
| 0.193 | 0.183 | 0.293 | 0.255 | 0.205 | 0.187 | 0.188 | 0.181 | 0.208 | 0.178 | 0.184 | 0.206 | 0.174 | 0.214 | 0.221 | 0.212 | 0.199 | 0.213 | 0.212 | 0.211 | 0.2 | 0.172 | 0.154 | 0.133 | 0.145 | 0.117 | 0.133 | -0.311 |